Therapy Areas: Cardiovascular
FMCNA Provides USD 20,000 Grant for American Nephrology Nurses Association Scholarships
19 September 2017 - - Waltham, Massachusetts-based health care company Fresenius Medical Care North America (FMCNA) is providing the American Nephrology Nurses Association (ANNA) a USD 20,000 grant fo...
BioCardia to Present Heart Failure Trial Design at Cardiovascular Regenerative Medicine Symposium in Houston
18 September 2017 - - San Carlos, California-based cardiovascular regenerative therapies developer BioCardia, Inc. (OTC: BCDA) will present the trial design for its pivotal Phase III CardiAMP Hea...
AstraZeneca reveals results from EXSCEL trial of diabetes drug Byduron
18 September 2017 - United Kingdom-based AstraZeneca has revealed complete results from the EXSCEL (EXenatide Study of Cardiovascular Event Lowering) trial that indicated cardiovascular safety for Byd...
Phosphorus Adds Ophthalmologic and Pharmacogenomic Tests
15 September 2017 - - New York, New York-based computational genomics company Phosphorus has expanded its catalogue with the addition of an ophthalmologic test for inherited conditions associated...
Chakravarthy Named Chief Medical Officer at Axcella Health
14 September 2017 - - US-based biotechnology company Axcella Health has hired Manu Chakravarthy, M.D., Ph.D as chief medical officer and senior vice president of clinical development, the company said...
Global Anaesthesia Drug Market to Grow at a CAGR of 3% from 2016-2023, Occams Business Research and Consulting Forecasts
14 September 2017 - - The global anaesthesia drug market is projected to rise at CAGR of 3% for the forecast period 2016-2023, according to a report from India-based Occams Business Research and Consu...